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Summary 
Interleukin 5 (I1`5) induces proliferation and differentiation of B cells and eosinophils by interacting 
with its receptor (I1`5R) which consists of two distinct polypeptide chains, c~ and j8 (~/c). Although 
both  I1`5Ro~ and /3c  lack  a  kinase  catalytic  domain,  I1`5 is  capable  of inducing tyrosine 
phosphorylation of cellular proteins. We investigated the role of I1`SKcx  in tyrosine phosphorylation 
of molecules involved in I1`5 signal transduction, using an I1`5-dependent early B cell line, Y16 
and transfectants expressing intact or mutant I1`5Rc~  together with intact/3c. The results revealed 
that the transfectants expressing truncated I1`SKcx, which entirely lacks a cytoplasmic domain, 
together with/3c, showed neither protein-tyrosine phosphorylation nor proliferation in response 
to I1`5. This confirms that I1`5Rc~  plays a critical role in protein-tyrosine phosphorylation which 
triggers cell growth. I1`5 stimulation results in rapid tyrosine phosphorylation  of/3c and proteins 
containing Src homology 2 (SH2) and/or SH3 domains such as phosphatidyl-inositol-3  kinase, 
Shc, Vav, and HS1, suggesting their involvement  in I1`5-mediated signal transduction. IL-5 
stimulation significantly enhanced activities of  Janus 2 and B cell-specific Bruton's tyrosine kinases 
(JAK2 and Btk) and increased the tyrosine phosphorylation ofJAK2 kinase. These results and 
recent data on signaling of growth factors taken together, multiple biochemical pathways driven 
by tyrosine kinases such as JAK2 and Btk are involved in I1`5 signal transduction. 
M 
ouse  II,5  (mI1`5) 1 plays an  important  role  in  the 
growth and differentiation of B cells and eosinophils 
(1-3). I1`5, I1`3, and GM-CSF display a variety of overlap- 
ping actions in the production and activation of eosinophils 
(4). mi1`5 binds to a specific  cell surface receptor (I1`5R) with 
both high (Ka, 10-150 pM) and low affinity (Ka, 2-10 riM). 
The receptor for I1`5 is composed of an oL chain (I1`5Rc~) 
of '~60 kD and a/3 chain (Bc) of '~130 kD (5-7). The I1` 
5Rc~ alone binds I1`5 with low affinity. The 13c does not 
1Abbreviatiom used in this paper: ~3c, common [3 chain for IL-5R, IL-3R, 
GM-CSFR; BTK, Bruton's tyrosine kinase; GAP, Ras GTPase activating 
protein; GRF, guanine nucleotide releasing factor; JAK, Janus kinase; mlL-5, 
mouse IL-5; Pl, phosphatidylinositol; PI.C, phospholipase C; FTK, protein 
tyrosine kinase;  PY, phosphotyrosine; SH, Src homology. 
The first two authors contributed equally to this work. 
bind Ib5 by itself, but does form a high affinity I1`5R in 
combination with I1`5Ro~ (6-10). The r  chain for both mouse 
and human Ib5R is specific for I1.,5 (6-11), whereas Bc is 
common to receptors for Ib3 and GM-CSF, as well (9, 11-16). 
Both I1`5rot and Bc are members  of the cytokine receptor 
superfamily, containing the hallmark WSXWS consensus se- 
quence and four conserved cysteine residues in the extracel- 
lular domain. The cytoplasmic domains share limited similarity 
with other cytokine receptors and lack detectable kinase cata- 
lytic domains.  Using a series of/3c mutants, two domains 
in the membrane-proximal  portion of/3c were found to be 
important for transducing human GM-CSF-mediated growth 
signals (17). 
Growth factors trigger proliferation of cells when they bind 
to their specific receptors. Receptors bound to a ligand pro- 
vide signals that are transmitted by means of biochemical reac- 
tion cascades (18). Phosphorylation of tyrosine residues on 
signal-transducing molecules is essential for activation of sig- 
naling pathways (18). Several  tyrosine-phosphorylated effector 
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factor receptors carrying intrinsic protein tyrosine kinase (~K) 
activity.  These  effector  molecules  are  phospholipase  C-3' 
(PI.C-~/),  phosphatidylinositol-3  (PI-3)  kinase,  and  Ras- 
associated GTPase-activating protein (GAP) (18). They con- 
tain Src-homology  2 (SH2) and/or Src-homology 3  (SH3) 
domains, the former of which binds to phosphorylated tyro- 
sine on protein (19),  whereas the latter has been suggested 
to be responsible for the targeting of signaling molecules to 
specific  subcellular locations (20). 
The shc gene codes for three protein products of "~46, 52, 
and 66 kD  (21) containing  a single COOH-terminal  SH2 
domain.  The  tyrosine-phosphorylated  Shc binds  to  Grb2 
which activates Sos protein, a Ras nucleotide-exchange pro- 
tein (22). Ras has been shown to work downstream of tyro- 
sine kinases in the growth signaling pathway (23-25). p95  ray 
(26) and p75 Hsl (27), which are expressed specifically in he- 
matopoietic cells and have SH2 and/or SH3 domains,  were 
recently  demonstrated  to  be  involved  in  B  cell  antigen 
receptor-mediated signaling (28, 29). Based on their unique 
sequences, these molecules were assumed to function as DNA 
binding proteins  (26,  27). 
Unlike several growth factor receptor families that possess 
intrinsic kinase domains, the receptors for cytokines have no 
cytoplasmic domain homology with any known enzymes in- 
volved in receptor-mediated signal transduction such as PTKs, 
protein serine/threonine  kinases,  or GAPs. However, tyro- 
sine phosphorylation of cellular proteins has been observed 
in various cytokine/cytokine receptor systems (30) and is be- 
lieved to be crucial in their signalling (31). A recently discov- 
ered family of nonreceptor tyrosine kinases, including Tyk2, 
Janus kinase  1 (JAK1), and JAK2, was suggested to be as- 
sociated with cytokine receptors including GM-CSF and II~3 
(32, 33). We have shown that I1.-5 induces distinct tyrosine 
phosphorylation of proteins migrating  at ~130 to 140, 92, 
53, 48, and 45 kD in the II.-5-dependent early B cell line, 
T88-M (34). Here we report that II~5Koe is essential for tyro- 
sine phosphorylation  of cellular proteins and cell prolifera- 
tion in response to Ib5. We demonstrate that II:5 stimula- 
tion induces rapid tyrosine phosphorylation  of ~c,  as well 
as proteins containing one or two SH2 and/or SH3 domains 
such as PI-3 kinase,  Vav, Shc,  and HS1. I1.-5 also increases 
tyrosine phosphorylation  of JAK2.  Furthermore,  I1.-5 acti- 
vates JAK2 and Bruton's  tyrosine kinase  (Btk)  (35,  36). 
Materials  and Methods 
Antibodies and Reagents.  Hamster  anti-mouse Bc mAb (HB) 
was prepared according to previously described methods (37) and 
purified from supernatants with serum-free medium using a protein 
G-Sepharose 4B column  (Pharmacia, Uppsala,  Sweden). Mouse 
antiserum to human HS1 was raised using proteins with the full- 
length sequence of human HS1 expressed in Escherichia coil Poly- 
clonal anti-GAP, PLC3,-1, PI-3 kinase, and Shc antibodies were 
purchased from Upstate Biotechnology, Inc. (Lake Placid, NY). 
Anti-Vav antibody was obtained from Santa Cruz Biotechnology 
Inc. (Santa Cruz, CA). Mouse anti-phosphotyrosine  (PY) mAbs, 
4G10 and PY20, were purchased from Upstate Biotechnology Inc. 
and ICN Biochemicals (Cleveland, OH), respectively. Rabbit anti- 
JAK1 and JAK2 sera were purchased from Upstate Biotechnology 
Inc. Rabbit anti-Btk serum was prepared by repeated injections of 
a peptide corresponding  to its unique region,  as described previ- 
ously (35). Rabbit anti-Fyn antibody was generated against a syn- 
thetic Peptide corresponding to amino acid residues 25-141 of the 
human Fyn protein sequence (38). Anti-Lyn mAb, Lyn-8, raised 
against a synthetic peptide corresponding  to the NH2-terminal- 
specific sequence (Arg-25 to Ala-119) of human Lyn protein (39) 
was kindly provided by Drs. Y. Yamanashi and T. Yamamoto (In- 
stitute of Medical Science, University  of Tokyo, Tokyo, Japan). 
Anti-Fyn and anti-Lyn antibodies reacted with both human and 
mouse Fyn and Lyn, respectively (38, 39). raiL-5 was prepared and 
purified using anti-mll.,5 mAb coupled beads (5). Herbimycin A 
was purchased from Wako Pure Chemicals Co. Ltd. (Tokyo,  Japan) 
and solubilized in DMSO. RPMI-1640,  and Hepes buffers were 
obtained from Nissui Pharmaceutical Co. Ltd. (Tokyo, Japan). 
Cell Lines and  Cell Culture.  A  mlL-2-dependent  cell line, 
CTLb2, was maintained in RPMI-1640 medium supplemented with 
10% FCS and 50/~M 2-ME and 5% conditioned medium from 
Con A-stimulated  rat spleen cells. A mlb3-dependent FDC-P1 
cell line was maintained in KPMI-1640 medium supplemented with 
5% FCS, 50 ~M 2-ME, and 5 U/ml of mlb3. mlL-5-dependent 
cell line, Y16 (6), was maintained  in KPMI-1640 medium  sup- 
plemented with 4% FCS and 50/~M 2-ME in the presence of raiL-5 
(5 U/ml). Before being used for assay, cell lines were washed three 
times with HBSS and incubated for 8 h at 37~  in fresh medium 
without cytokines. The following transfectants were used in this 
study (6, 9, 16): FDC-SK, transfectants of Ib5Rc~ cDNA; FDC- 
5Kc~Acyto, transfectants of the mutated c~ chain cDNA lacking 
the entire cytoplasmic domain of the c~ chain; CTLDSRc~, CTLL-2 
transfectants of IL-5Rc~ cDNA; and CTLbSRc~/B, CTLL-2 trans- 
fectants of cDNAs for both I1r  and Bc. 
Proliferation Assay.  Y16 cells were harvested and washed with 
HBSS, then inoculated onto a 96-weU  microtiter plate at a concen- 
tration of 104/200/~l/well with KPMI-1640 containing 4% FCS 
at 37~  for 8 h and subsequently cultured with 2,000 U/ml raiL-5 
at 37~  for 36 h (6). Herbimycin A (3/~g/ml) was dissolved in 
the culture medium containing  DMSO and added at the begin- 
ning  of the culture.  As a control,  DMSO-containing  medium 
without herbimycin A was added. The cells were pulse labeled with 
[3H]thymidine (0.2 #Ci/well) during the last 12 h of the culture 
period and transferred onto fiberglass filters. [3H]Thymidine in- 
corporated into cells  was measured with a liquid scintillation counter. 
The viability of Y16 cells after the herbimycin A treatment  was 
determined by trypan blue dye exclusion test. 
Preparation of Cell Lysates.  Y16,  FDC-5Kc~, FDC-5K~Acyto, 
CTLL-5Kc~ and CTLD51Lo~/~/cells  were deprived of cytokines for 
the 8 h of incubation before stimulation  with the cytokine indi- 
cated.  Subsequently,  cells were  cultured  at  107 cetls/ml  with 
2,000 U/ml Ib5, 1,500 U/ml Ib3, or 2,000 U/ml IL-2 for various 
periods of time at 37~  They were then harvested by centrifuga- 
tion and lysed in ice-cold lysis buffer (1-4  x  107 cells/ml) con- 
taining 20 mM Tris-HC1, pH 7.4, 150 mM NaC1, 1% Triton X-100, 
10% glycerol, 2 mM EDTA, 100 U/ml aprotinin,  1 mM NaF, 1 
mM PMSF, and 1 mM Na3VO4. Unsolubilized materials were re- 
moved by centrifugation  for 15 rain at 12,000 g. The cell lysates 
thus obtained were subjected to immunoprecipitation.  Lysates  pre- 
pared from 2  x  107 cells were mixed with an equal volume of 2X 
Laemmli sample buffer, and boiled for 5 rain. Samples were elec- 
trophoresed on SDS-polyacrylamide gels (8%). 
Immunoprecipitation.  1-ml  quantifies of the above  cell lysates  were 
precleared with protein G-Sepharose 4B and the resulting samples 
were incubated at 4~  for 60 min with 2-10/~g of the antibodies 
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G-Sepharose during a 60-min incubation at 4~  washed three times 
with lysis buffer, and then  two times with washing  buffer con- 
raining 20 mM Tris-HCl, pH 7.4, 150 mM NaC1, and 10% glycerol, 
and finally boiled for 5 min with 2X Laemmli's sample buffer. 
Western  Blotting.  Samples  were subjected to 8% SDS-PAGE  and 
electrotransferred to a polyvinylidene difluoride (PVDF) filter (Mil- 
lipore Corp.,  Bedford, MA) according to the manufacturer's  in- 
strnctions. Filters were blocked with buffer containing 20 mM Tris- 
HCI, pH 7.6,  150 mM NaC1, 0.05% thymerosal,  and 5% BSA 
(Fraction V; Sigma Chemical Co.,  St. Louis, MO). For Western 
blotting of PY-containing proteins, the filter was incubated with 
1 #g/ml 4G10 or 2/~g/ml PY20 for 2 h, and washed four times 
with washing buffer containing 0.05% Tween 20. Phosphorylated 
proteins  were then  detected  with  enhanced  chemiluminescence 
(ECL) assay  kit (Amersham International, Amersham, Bucks, UK). 
In some of the experiments, l~I-labeled PY20 (ICN Biochemicals) 
was used to detect tyrosine-phosphorylated  proteins that were de- 
tected by autoradiography,  as indicated. 
In Vitro Kinase Assay.  Cell lysates were mixed with anti-Lyn 
mAb, polyclonal anti-Btk, anti-Fyn, anti-JAK1 or anti-JAK2 anti- 
bodies  and  immune  complexes  were  collected  using  protein- 
G-Sepharose  and suspended in kinase buffer containing  40 mM 
Hepes, pH 7.4, 10 mM MgCI2, 3 mM MnC12, 0.1%  NP-40, and 
30/xM Na3VO4. In some experiments, enolase (5/~g/each sample) 
denatured with acetic acid was added as an exogenous substrate. 
After  addition  of 4  /~M  ATP  and  20  #Ci  3,[32P] ATP  (4,500 
Ci/mM; ICN Biochemicals), the mixture was incubated for 5 min 
at 25~  The samples  were diluted twice with 2X Laemmli's sample 
buffer and boiled for 5 min.  Eluates were subjected to 8% SDS- 
PAGE, the gels were treated with 1 M KOH for 2 h at 55~  and 
phosphorylated proteins were visualized with a Bio-image analyzer, 
BAS2000 (Fuji Film Co. Ltd.,  Tokyo, Japan). 
Results 
Herbimycin A  Inhibits the IL-5-induced Proliferation of  an Early 
B CelILine.  Satoh et al. (40) and Sakamaki et al. (17) reported 
that  herbimycin  A,. a  spedfic inhibitor  of tyrosine kinase, 
blocked IL-3 and GM-CSF-dependent cell proliferation and 
suggested the importance of tyrosine kinases in ligand-induced 
cell proliferation. To evaluate whether protein tyrosine phos- 
phorylation is essential for Ib5-induced cell proliferation, the 
effects of herbimycin A on IL-5-induced tyrosine phosphory- 
lation and cell proliferation were examined using an Ib5-de- 
pendent cell line Y16.  Herbimycin A  did not show a toxic 
effect sufficient to cause death in Y16 cells at concentrations 
<5 #g/ml under the conditions employed. As shown in Fig. 
1,  tyrosine phosphorylations  of cellular proteins  migrating 
at  ~130,  90,  and  60 kD  were detected in IL-5-stimulated 
Y16 cells. The addition of herbimycin A, but not the DMSO 
used as a control, resulted in the inhibition of these tyrosine 
phosphorylations  (Fig.  1 A)  as well as the  suppression  of 
Ib5-dependent proliferation (Fig.  1 B). The inhibitory effects 
of herbimycin A were markedly reduced by the addition of 
2-ME, an inhibitor of herbimycin A (data not shown). These 
results indicate that tyrosine phosphorylation of multiple in- 
tracellular substrates is a prerequisite for IL-5-dependent cell 
proliferation. 
The Cytoplasmic Domain of the IL-5Rce is Involved in Gener- 
Figure 1.  Inhibition  of tyrosine  phosphorylation and cell  proliferation 
of Y16 cells by herbimycin A. (A) Y16 cells were incubated for 8 h in 
RPMI-1640 containing 4% FCS and 3/~g/ml herbimycin A, or DMSO 
as a control, in the absence  of IL-5. Cells were then treated with 2,000 
U/ml mlL-5 for 5 min at 37~  and lysed  with 1% Triton X-100. Samples 
were separated  by SDS-PAGE  (8% polyacrylamide  gel) and iramunoblotted 
with 12SI-labeled  PY20. The major tyrosine-phosphorylated  proteins are 
indicated by arrows. The indicated marker proteins are given (kDa). (/3) 
After being treated with herbimycin A or DMSO, cellular proliferation 
data were assessed  in terms of [3H]TdR.  incorporation into DNA after IL5 
stimulation. 
ating a Signal for Tyrosine Phosphorylation.  To envisage the 
roles of Ib5Rot and/~c in IL-5-induced tyrosine phosphory- 
lation,  we reconstituted IL-5R in an Ib2-dependent  T  cell 
line, CTLb2, by transfecting cDNAs for Ib5Rol either with 
or without Bc. CTLL-5Rot//~ transfectants, expressing both 
Ib5Ro~ and/8c,  proliferated  in response to  IL-5 as well as 
to Ib2 (16).  IL-5 stimulation induced rapid protein tyrosine 
phosphorylation  of subcellular proteins  and  these tyrosine 
phosphorylations  had diminished  slightly by 30 min  (Fig. 
2  A).  II,2  stimulation  of the  same  transfectants  induced 
a distinct  protein  tyrosine phosphorylation  similar  to that 
observed in response to Ib5, except that  the tyrosine phos- 
phorylation  of the  130-140 kD protein was not  observed. 
CTLL-5Ka transfectants  expressing  Ib5Rot alone showed no 
detectable levels of tyrosine phosphorylation in response to 
II.-5, although they had patterns of tyrosine phosphorylation 
in response to IL-2 similar to that observed in CTLL-5Rot//~ 
transfectants (Fig. 2 B). These data indicate that/~c, together 
with Ib5Kot, are required for induction of  both protein tyro- 
sine phosphorylation  and cell proliferation. 
We also investigated the role of IIr  in IL-5-induced 
tyrosine phosphorylation.  We stimulated FDC-P1 transfec- 
tants expressing either intact II~5Kot (FDC-SKo  0  or a mu- 
tant  Ib5Koe (FDC-5Kc~Acyto), in  which the c~ chain  has 
no cytoplasmic domain (6, 16), with IL-5 or IL3. As described 
previously (16),  both  FDC-SRc~ and FDC-SKotAcyto ex- 
pressed high affinity IL-SR, but FDC-5RotAcyto showed no 
proliferative  response  to  II.,5.  As  shown in  Fig.  3 A,  the 
rapid  tyrosine phosphorylation  of FDC-5Rc~ cellular  pro- 
teins was observed in response to both IL-5 (Fig.  3 A) and 
I1.-3 (Fig.  3 B). This  tyrosine phosphorylation  had dimin- 
ished slightly by 30 rain after IL-5 stimulation.  In contrast, 
FDC-5KotAcyto did not show a significant protein tyrosine 
phosphorylation in response to Ib5 (Fig.  3 A), while again 
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stimulated  CTLb2 transfectants.  Ib2-dependent  T call  line  CTLL-2  trans- 
fectants (CTLL.5RoL and CTLL.5RolB) were treated with 2,000 U/ml 
mlb5 (A) or 2,000 U/m1 mIL-2  (/3) for 0, 1, 5, or 30 min at 37~  The 
cells were  lysed  with 1% Triton  X-100 after  stimulation.  Cell  lysates  were 
separated  by SDS-PAGE (8% polyacrylamide  gel) and immunoblotted  with 
the anti-PY mAb. The indicated marker proteins are given (kDa). 
Figure 3.  Protein  tyrosine  phosphorylation  in Ib3- or IbS-stimulated 
FDC-P1 transfectants.  II.~3-dependent  myeloid  call line, FDC-P1 trans- 
fectants (FDC.5Rc~cyto and FDC-5Ro  0 were treated  with 2,000 U/ml 
mIb5 (A) or 1,500 U/m1 mlL-3 (B) for 0, 1, 5, or 30 rain at 37~  The 
cells were lysed  with 1% Triton  X-100 after the stimulation.  Cell  lysates 
were separated  by SDS-PAGE  (8% polyacrylamide  gel) and immunoblotted 
with anti-PY mAb. 
showing a pattern of tyrosine phosphorylation in response 
to I1.3 similar to that observed in FDC-5R.oe (Fig. 3 B). These 
results indicate that the cytoplasmic region of I1.SRoL is es- 
sential,  together with tic, for generating the signal for pro- 
tein tyrosine phosphorylation in response  to I1.5. 
The Tyrosine-phosphorylated Protein Migrating at 130-140 kD 
is tic.  One tyrosine-phosphorylated protein,  initially mi- 
grating at ,'o 130 kD, subsequently increased to 140 kD, over 
a period of 20 rain, after stimulation of cells with I1.5 or 
Ib3 (Figs. 2 and 3, and Fig. 4 lanes 2 and 4). As shown in our 
previous  study (8),  the molecular mass of tc is '~130 kD. 
Thus, the tyrosine-phosphorylated  protein migrating at -130 
kD was assumed to be tc. The 130-140  kD protein phos- 
phorylated in response  to I1.5  was  shown to be primarily 
tc by immunoprecipitation and absorption experiments using 
the anti-tc mAb, HB (37). When cell lysates of I1.5-stimu- 
lated Y16 cells were absorbed with the HB mAb, the tyrosine- 
phosphorylated band of 130-140 kD protein disappeared (Fig. 
4, lane 3), whereas most other tyrosine~phosphorylated bands 
remained. Bc was then immunoprecipitated with HB and ana- 
lyzed for tyrosine phosphorylation by SDS-PAGE followed 
by Western blotting using 12SI-labeled PY20.  As shown in 
Fig. 4, Bc was tryosine phosphorylated after II-5 stimulation 
(lane 4). We also observed that weakly tyrosine-phosphorylated 
proteins migrating at 40 and 100 kD coprecipitated with tc. 
These data dearly demonstrate that the markedly tyrosine- 
phosphorylated 130-140 kD protein is tc. The 40- and 100-kD 
proteins may be associated  with tc. 
PI-3  Kinase,  Vav, Shc, and HS1  Protein are  Tyrosine Phos- 
phorylated upon IL,5 Stimulation.  We then investigated I1-5-in- 
duced tyrosine phosphorylations of PLC-% GAP,  PI-3 ki- 
nase,  Shc,  p95 vav  and  p75 Hsl,  all  of which  contain  SH2 
and/or SH3 domains. Immunoprecipitation followed by im- 
munoblot analysis of cell lysates of I1-5-stimulated Y16 cells, 
2104  IL-5-mediated  Signal Transduction Figure 4.  Immunoprecipitation  of 
the 130-kD  phosphoprotein  with  anti- 
IL-SRB chain mAb. Y16 cells were 
treated with 2,000 U/ml mlL-5 for 
5 rain at 370C, and their cell lysates 
were preabsorbed  (Abs.), immunopre- 
cipitated (Ira.R) with HB mAb. Im- 
munoprecipitates were separated by 
SDS-PAGE (8% polyacrylamide  gel) 
and immunoblotted  with 124I-labeled 
PY20. The position to which the Bc 
migrated  is indicated  by an arrow,  and 
the indicated  marker  proteins  are given 
(kDa). 
using polyclonal or monoclonal antibodies specific for each 
of the above proteins, revealed that Y16 cells expressed  all 
of the  aforementioned molecules.  The  cell  lysates  of I1. 
5-stimulated Y16 cells immunoprecipitated with anti-PI-3 
kinase antibody, followed by immunoblotting with anti-PY 
mAb, revealing that marked tyrosine phosphorylation of PI-3 
kinase had occurred in  response  to 1I.-5 stimulation (Fig. 
5).  In contrast,  no bands corresponding to tyrosine-phos- 
phorylated PLC-3~ or GAP were detected, under similar assay 
conditions, by immunoprecipitation with antibodies specific 
for each respective  protein regardless  of how long the ceils 
were stimulated with I1.5  (1-30  min).  No tyrosine-phos- 
phorylated protein bands were observed even when the samples 
were immunoprecipitated with anti-PY mAbs (4G10 or PY20) 
and then immunoblotted with anti-PLC-3, or anti-GAP an- 
tibodies. It is intriguing that Vav, Shc, and HS1 proteins were 
tyrosine phosphorylated within 5 rain of being stimulated 
with Ib5 (Fig. 6) but had disappeared  by 30 min after Ib5 
stimulation (data not shown). It was clear that the tyrosine- 
phosphorylated protein  with  an  ~130-kD  band  was also 
coprecipitated with Shc by anti-Shc antibodies. No tyrosine 
phosphorylations of any of these SH2/SH3-containing pro- 
teins was observed in I1.5-stimulated FDC-SRotAcyto (data 
not shown). 
JAK2 is Tyrosine Phosphorylated and Activated by 11-,5 Stimu- 
lation.  The fact that tyrosine phosphorylation of cellular pro- 
teins including/3c can be rapidly induced after I1-5 stimula- 
tion indicates the association of FTK with I1-5R along with 
I1.5 stimulation. However, we could not detect any tyrosine 
kinase activity in the immunoprecipitates using anti-13c mAb, 
HB, or anti-IL-5Rot mAb, H7 of the lysates from I1-5-stimu- 
lated Y16 cells. Recent studies have shown that theJAK family 
of  cytoplasmic FFKs were associated with some of the cytokine 
receptors  including I1-3R, and tyrosine phosphorylatedjust 
after the binding of ligand to the receptor.  Tyrosine phos- 
phorylation of a kinase is believed to be important in trans- 
mitting a signal to downstream of SH2-containing effector 
molecule(s).  Thus, we examined whether the tyrosine phos- 
phorylation of  JAK1 and JAK2 kinases occurs upon Ib5 stim- 
ulation. Cell lysates of I1-5-stimulated Y16 cells were sub- 
mitted to immunoprecipitation by antibodies specific for  JAK1 
Figure 5.  Detection  of  tyrosine-phosphorylated  GAP,  PLC-%  and PI-3 
kinase  in II,5-stimulated  Y16 cells. Y16 cells  were  treated  with 2,000 U/m1 
raiL-5 for 5 min at 37~  lysed  with 1% Triton  X-100, and immunopre- 
cipitated with anti-GAP, anti-PLC-%  or anti-Pl-3 kinase antibodies. Im- 
munoprecipitates  were subjected  to SDS-PAGE analysis  on 8-10% poly- 
acrylamide  gels, and immunoblotted  with anti-IvY  mAb. The positions 
to which GAP, PI.C-% and PI-3 kinase  migrated  are indicated  by arrows, 
and marker proteins are given (kDa). 
or JAK2 kinase and then precipitates  were immunoblotted 
with anti-PY mAb. As shown in Fig. 7 A, marked tyrosine 
phosphorylation of JAK2 but not ofJAK1 kinase,  was ob- 
served upon 11.-5 stimulation of Y16 cells. This phosphoryla- 
tion was detected as early as 10 s after Ib5 stimulation (data 
not shown), suggesting that JAK2 kinase is located prox- 
imal to the activated I1.5R and function upstream of the Ib5 
signaling. To assess the effects on kinase activities of JAK1 
and JAK2, JAK1 or JAK2 was immunoprecipitated from the 
lysates of Ib5-stimulated Y16 cells and in vitro kinase assays 
were performed. No in vitro kinase activity was detected in 
immunoprecipitates with JAK1 antiserum from unstimulated 
or stimulated cells (Fig. 7 B). However, immunoprecipitates 
from Ib5-stimulated Y16 cells with JAK2 antiserum con- 
tained kinase activity and resulted in tyrosine phosphoryla- 
tion of a protein of 130 kD that comigrated with JAK2. In 
contrast, the 130-kD band was not detected with unstimu- 
lated cells. This suggests that JAK2 is activated along with 
IL-5R ligation. 
Btk Is Activated by 11-,5 Stimulation.  Btk was recently doned 
as a B cell-specific  cytosolic tyrosine kinase and identified 
Figure  6.  Detection  of tyrosine-phosphorylated  Sch, Vav, and HS1 in 
Ib5-stimulated  Y16 cells.  Y16 cells  were  stimulated  with  2,000 U/ml  mIb5 
for 5 min at 37~  lysed  with 1% Triton  X-100, and immunoprecipitated 
with anti-Shc, anti-Vav,  or anti-HS1 antibodies.  Immunoprecipitates  were 
analyzed  by SDS-PAGE (8-10% polyacrylamide  gel) and immunoblotted 
with anti-IVy mAb for detection of phosphoryhted  Shc and HS1, or 
~I-labeled PY20, for detection of phosphorylated  Vav. The positions to 
which Shc, Vav, and HS1 migrated  are indicated  by arrows, and marker 
proteins are given (kDa). 
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(A) and activation (B) or JAK2 tyro- 
sine kinase  upon IL-5  stimulation  of  Y16 
cells. (A) Y16 cells  were stimuhted with 
2,000 U/ml raiL-5 for 5 rain at 37~ 
The lysates were subjected to Western 
blotting using anti-PY  mAb (4G10) and 
tyrosine-phosphorylated  bands were de- 
tected by ECL assay. The positions to 
which JAK1 and JAK2 migrated are in- 
dicated by arrows and marker proteins 
are given (kDa). (/3) Immunoprecipi- 
tates of (A) were subjected to in vitro 
kinase assay  as described  in Materials  and 
Methods and separated by SDS-PAGE 
(8%).  The gel was treated with 1 M 
KOH at 55~  for 2 h. Tyrosine-phos- 
phorylated bands were detected by au- 
toradiography. The position to which 
JAK2 migrated is indicated by arrows, 
and marker proteins are given (kDa). 
as the molecule involved in X-linked  human  agammaglob- 
ulinemia (XLA) (35, 36). A  single conserved residue within 
the  NH2-terminal  unique  region  of Btk  was  shown  to be 
mutated in XID mice (42, 43), in which B cells showed im- 
paired responsiveness to II:5 (44). Lyn and Fyn kinases were 
reported to be associated with B  cell antigen receptors  and 
to play roles in B cell development,  and have also been sug- 
gested to be associated with the signaling cascade mediated 
by Ib3R (45) and GM-CSFR (34) in myeloid cell lines. Thus, 
we examined the effects of I1:5 on tyrosine phosphorylation 
of Btk, Lyn, and Fyn as described above. However, we could 
not detect any significant increase in phosphorylation of these 
kinases upon  II.-5 stimulation  (data not  shown).  Next,  we 
investigated  kinase  activities  for Btk,  Lyn,  and  Fyn in  I1: 
5-stimulated Y16 cells. Cell lysates were immunoprecipitated 
with anti-Btk, anti-Lyn, or anti-Fyn antibodies,  and each of 
the immunoprecipitates was used for an in vitro kinase assay. 
We monitored  kinase  activities by autophosphorylation  of 
each kinase and the phosphorylation of enolase, an exogenously 
added  substrate.  We  confirmed  that  all  kinase  reactions 
Figure  8.  Time courses of Btk (A) and Lyn (B) kinase activities in Ib5-stimulated Y16 cells. Y16 cells were stimulated with 2,000 U/ml mlb5 
for 0, 5, 30, or 60 min. Cells were lysed with 1% Triton X-100 and immunoprecipitated with anti-Btk or anti-Lyn antibodies. Immune complexes 
were subjected to SDS-PAGE  analysis on 8% polyacrylamide  gds. Kinase assays  were conducted as described in Materials and Methods. Kinase activity 
was detected by autoradiography. (A) Autophosphorylation and enolase phosphorylation resulting from anti-Btk immune complex kinase assay  were 
revealed  by autoradiography. The positions to which Btk and enolase migrated are indicated and marker proteins are given (kDa). (/3) Autophosphoryla- 
tion and enolase phosphorylation, resulting from the immune complex kinase assay of immunoprecipitates using anti-Lyn antibodies, were detected 
by autoradiography. The position of Lyn and enolase migrated are indicated and marker proteins are given (kDa). 
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Figure  9.  Time course of ID5-induced increases in Btk ki- 
nase activity in Y16 cells. Y16 cells were treated with 2,000 
U/ml mlL-5 for 0, 5, 30, or 60 min. The Btk (A) and enolase 
(B) bands  seen in Fig. 8 (A) were excised from the gel and 
subjected  to  32p  counting.  Results  from  a  series  of five 
different experiments  are shown. 
proceeded linearly, for up to 20 min at 25~  under our assay 
conditions.  As  shown in Fig.  8 A  and Fig.  9, A  and B, 
significantly enhanced Btk kinase activity (two to three times 
higher than that of unstimulated controls)  was detected in 
anti-Btk immunopredpitates  of Y16 cells stimulated with Ib5 
for 5-20 min by both the autophosphorylation and the eno- 
lase assay. In contrast,  no significant enhancement of either 
Lyn (Fig. 8 B) or Fyn (data not shown) kinase activity was 
detected under the conditions employed. No enhanced Btk 
activity was detected in IL-5-stimulated FDC-SKoeAcyto (data 
not shown). 
Discussion 
We describe three major observations in this study: (a) The 
cytoplasmic domain of IDSRot is indispensable, together with 
Be, for IL-5-mediated signaling; (b) signal transducing mol- 
ecules having SH2 and/or SH3 domains, such as PI-3 kinase, 
She, Vav, and HS1 proteins, are rapidly tyrosine phosphorylated 
in response to II.-5; and (c) the activity ofJAK2 kinase and 
B cell-specific Btk is significantly enhanced after Ib5 stimu- 
lation. Tyrosine phosphorylation of  JAK2 is rapidly induced 
upon stimulation with IL-5. 
There is ample evidence that tyrosine phosphorylation of 
membrane receptors and cellular proteins is important for the 
regulation of receptor-mediated  signal transduction. Tyro- 
sine phosphorylation of cellular proteins have been reported 
in both II-3- and GM-CSF-stimulation cells (34, 45-49) and 
patterns of protein tyrosine phosphorylation showed no ap- 
parent differences among these cytokines.  As ~c is shared 
among receptors for IL-3, IL-5, and GM-CSF (6-11) and is 
indispensable for their signal transduction pathways, ID5 signal 
transduction is assumed to be similar to that of ID3R and 
GM-CSFR systems. In fact, stimulation of IL-5-dependent 
T88-M cells with II.-5 induced tyrosine phosphorylation of 
multiple subcellular proteins similar to those induced by I1.-3 
(34). This was further confirmed in the present study using 
CTLL transfectants expressing recombinant ID5Rot and/5c 
(Fig. 2). The importance of tyrosine phosphorylation in Ib5 
signal transduction was strengthened by experiments  using 
herbimycin A. Treatment of IL-5-dependent Y16 cells with 
herbimycin A, a tyrosine kinase inhibitor, induced the inhi- 
bition of not only protein tyrosine phosphorylation,  but also 
the cell growth induced by I1--5 (Fig.  1). 
2107  Sato et al. 
We reported that  FDC-5RotAcyto,  an  IL-3-dependent 
FDC-P1 transfectant of a mutated IL-5Rot eDNA which lacks 
the entire cytoplasmic domain, shows no proliferative response 
to IL-5, although it can bind IL-5 with high affanity (16), 
indicating that the cytoplasmic domain of ID5Rot is required 
for IL-5-induced cell proliferation. Furthermore, stimulation 
of FDC-SRoLAcyto with IL-5 did not induce protein tyro- 
sine phosphorylation (Fig. 3), although tyrosine phosphory- 
lation did occur in response to IL-3 to an extent similar to 
that observed in its parental cell line, FDC-P1. These results 
indicate that ID5Rot has two functions crucial for generating 
a growth signal: one is to bind I1.-5 on the receptor and the 
other is to interact with Bc to generate a signal for protein 
tyrosine phosphorylation. We cannot adequately explain the 
role of the cytoplasmic domain of IL-5Rot in IL-5-mediated 
signaling. Like receptors with tyrosine kinase domains in their 
cytoplasmic domains, binding of IL-5 to IL-5Ret might in- 
duce dimerization of Bc, a signal transducer resulting in acti- 
vation of PTKs. It is also possible that Ib5Rc~, in combina- 
tion with/3c, might form the site for association with tyrosine 
kinase(s). We are currently approaching an understanding of 
these issues, based on the results of testing IL-5 responsive- 
ness and tyrosine phosphorylation  of transfectants expressing 
chimeric IL-5R containing the c~ chain in the extracellular 
and transmembrane domains and/$c in the cytoplasmic do- 
main together with intact Be. 
The tyrosine phosphorylation of/~c among cellular pro- 
teins was most abundant in IL-5-stimulated  Y16 cells (Fig. 
4). When we immunoprecipitated cell lysates with anti-/$c 
mAb, two different phosphorylated proteins, of ,,o40 and 100 
kD were also coprecipitated. These proteins may be associated 
with Bc and may have been phosphorylated in response to 
Ib5 stimulation. Tyrosine phosphorylation of the 3c of IL- 
3R or GM-CSFR has also been reported (47-49),  although 
any molecules associated  with/$c were not identified. Sakamaki 
et al. (17), using a series of Bar transfectants of jBc eDNA 
with deletions of various regions, described significant 3c- 
mediated tyrosine phosphorylation of cellular proteins as ap- 
parently being distinct from proliferation.  At this moment, 
we have no evidence for the dissociation of IL-5-induced pro- 
tein tyrosine phosphorylation of/8c and Ib5-induced cell 
proliferation. 
Among signal-transducing molecules for cell growth, such 
as PLC-3', GAP, and PI-3 kinase, which have SH2 domains for interacting with tyrosine kinase, we detected significant 
tyrosine phosphorylation of PI-3 kinase in response to II~5 
stimulation (Fig. 5). PI-3 kinase is a lipid kinase that phos- 
phorylates the D3 position of phosphatidyl inositol, phos- 
phatidyl inositol-4-phosphate and PI-4,5-P2 (50). PI-3 kinase 
consists of an 85-kD regulatory subunit and a 100-kD cata- 
lytic subunit. The p85 regulatory subunit harbors two tyro- 
sine  phosphate binding domains,  SH2  domains,  and  the 
majority of the tyrosine residues in PI-3 kinase that serve 
as the substrates for various PTKs both in vivo and in vitro 
(51). Recent evidences indicate that PI-3 kinase is probably 
activated directly by the process of binding via its SH2 do- 
mains to specific tyrosine phosphate residues that are located 
in signaling complexes  and are the products of receptor- 
stimulated PTKs. It was reported that Ib4 caused a strong 
association of PI-3 kinase with tyrosine-phosphorylated 170- 
kD  protein whereas IL3 induced an association  of phos- 
phorylated 97-kD protein with PI-3 kinase (52). Although 
it is unclear what role tyrosine phosphorylation of the p85 
regulatory subunit plays in PI-3 kinase activation, the phos- 
phorylation may indicate the interaction of PI-3 kinase with 
tyrosine-phosphorylated PTK  through  its  SH2  domain. 
Yamanashi et al. (39) demonstrated that cross-linking of B 
cell antigen receptor induces tyrosine phosphorylation of the 
p85 regulatory subunit followed by activation of PI-3 kinase, 
which was associated with Lyn, a src-like PTK. It was re- 
cently shown that the universally expressed PKC-~" is acti- 
vated by the products of PI-3 kinase (53) and is critical for 
mitogenic signal transduction (54). The activation of PKC-~', 
mediated through phosphorylated PI-3 kinase after IL5 stim- 
ulation, might be involved in the IL-5-mediated growth signal 
cascade and in the platelet-derived  growth factor-mediated 
cascade as well (55). 
It  has  been  suggested that  P21  r~  (Ras)  functions as  a 
signal-transducing molecule downstream from PTK(s) (22, 
23). Ras has been reported to be activated after ligand stimu- 
lation in IL-3K-, GM-CSFK- and IL-5R-mediated signaling 
pathways (24, 25) and in antigen receptor-mediated signal 
transduction (56, 57). It was recently clarified (21) that the 
tyrosine-phosphorylated Shc protein functions as an adapter 
because of its association with Grb2, another adapter pro- 
tein. Grb2 binds to both Shc and mSos through its SH2 and 
SH3 domains, respectively, mSos is a Ras nucleotide exchange 
protein and activates Kas (25). Satoh et al. (40) demonstrated 
that the increase in Ras-GTP, as well as cell proliferation in- 
duced by IL-3 and GM-CSF was diminished in cells treated 
with herbimycin A, suggesting the involvement of tyrosine 
kinase(s) in the Ras activation pathway mediated by these 
cytokines. We have shown that Shc protein (p52 she) is tyro- 
sine phosphorylated in response to IL-5 stimulation (Fig. 6). 
In these experiments, we also detected a tyrosine-phosphor- 
ylated protein of'v 130 kD which coimmunoprecipitated  with 
Shc in the presence of anti-Shc antibodies. This protein might 
be ~c, because its mol wt is similar  to that of Bc and we 
are currently testing this possibility. As tyrosine phosphory- 
lation of Ras-GAP was not induced by Ib5 stimulation (Fig. 
5); enhanced Ras activity may not be caused by tyrosine phos- 
phorylation of GAP in conjunction with I1,-5 stimulation. 
Therefore, activation of Ras in response to II,-5 stimulation 
is, at least in part, due to modulation of Shc by the tyrosine 
kinase(s) activated by Ib5 binding. 
The p95Wv(Vav), a proto-oncogene product specifically 
expressed in hematopoietic cells, contains a single SH2 and 
two SH3 domains as well as sequence motifs commonly found 
in transcription factors, such as the helix-loop-helix, leucine 
zipper, and zinc-finger motifs, and nuclear localization signals, 
in addition to being homologous with guanine nucleotide 
releasing factors (GKFs) (58). We observed that Vav was rap- 
idly tyrosine phosphorylated upon stimulation with II.-5 (Fig. 
6). Vav was also shown to be tyrosine phosphorylated upon 
cross-linkage of the antigen receptors on T and B cells (59). 
Recently, Gulbins et al. (58) demonstrated that both the tyro- 
sine phosphorylation of Vav and the Vav-associated GRF ac- 
tivity for Kas were enhanced after TCK cross-linking.  They 
proposed the concept that Vav is a tyrosine kinase--regulated 
GKF which is important in TCK-initiated signal transduc- 
tion through activation of Ras. Therefore, the tyrosine phos- 
phorylation of Vav observed in this study may be associated 
with the increase in the active form of Ras in IL-5-stimu- 
lated Y16 cells. It is also possible that, as expected from its 
structural homology, Vav plays other crucial roles as a tran- 
scriptional factor in the II~5-induced gene expression associated 
with cell growth. 
The HS1 gene is expressed specifically in cells of hemato- 
poietic lineage (27). The NH2-terminal moiety of HS1 pro- 
tein has three copies of a 37-amino acid repeating motif, each 
of which contains a helix-turn-helix motif. The COOH- 
terminal portion has a potential or-helix containing an am- 
phipathic region. In addition, an SH3 motif was identified 
near the COOH-terminus. HS1 is a major substrate of PTKs 
activated by binding of the B cell antigen receptors,  mlgM 
and mlgD. As is evident from Fig. 6, the HS1 protein was 
also tyrosine phosphorylated upon stimulation with Ib5. Re- 
cently, an association of HS1 protein with Lyn tyrosine ki- 
nase was found in B cells activated by cross-linking of their 
mlgM with anti-IgM antibodies (29). Based on its structural 
homology, HS1 is assumed to function as a DNA binding 
protein. Our observations  of the tyrosine phosphorylation 
of HS1 in response to II,5 stimulation (Fig. 6) indicate that 
HS1 may transduce a signal generated by Ib5 ligation directly 
into the genetic loci involved in IL-5-induced cell growth. 
Recently,  Larner et al. (60) demonstrated that treatment of 
human peripheral blood monocytes or basophils with IL-3, 
II.-5, IL-10, or GM-CSF activated the DNA binding proteins 
whose tyrosine residues were phosphorylated. They suggested 
that these cytokines, as well as IFN-c~ and IFN-% can modu- 
late gene expression through activation of putative transcrip- 
tion factors by tyrosine phosphorylation. Both Vav and HS1 
might be involved in the formation of such a DNA-binding 
complex. 
As for tyrosine kinase(s) involved in Ib5K-mediated sig- 
naling,  clarification  of this process  has been problematic. 
Torigoe et al. (45) have shown the activation of Lyn kinase 
to be  associated  with  IL-3-,  but  not  with II_,2-induced, 
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demonstrated that both Lyn and Yes kinases were activated 
and  associated  with  PI-3  kinase  in  GM-CSF-stimulated, 
myeloid-derived cells. Hanazono et al. (49) reported that both 
GM-CSF and II.-3 can induce tyrosine phosphorylation and 
activation of c-fps/fes  PTK in human erythroleukemic cell 
line. A new family of cytoplasmic PTKs, the JAKs (alterna- 
tively referred to as just another kinase family), consisting 
of JAK1, JAK2,  and Tyk2, has been described  and cloned 
(32, 61, 62). In addition to a kinase domain, these proteins 
are characterized by the presence of a second kinase-like do- 
main and the absence of SH2, SH3, and membrane-spanning 
domains. The Tyk2 has been implicated in IFN-ol receptor 
signal transduction (32). More recently, a variety of different 
cytokines including erythropoietin, growth hormone, Ib3, 
GM-CSF, G-CSF, and IFN-3, has been found to induce tyro- 
sine phosphorylation and kinase activation of  JAK2 (33, 63). 
In the current study, JAK2 was shown to be very rapidly 
(within 10 s) tyrosine phosphorylated and activated by ID5 
stimulation. This suggests that upon stimulation, JAK2 is 
located proximal to IbSR and involved in an ID5R-medi- 
ated signal  transduction. 
We demonstrated that Btk was activated by II.-5 stimula- 
tion of pre-B  cell lines (Figs. 8 and 9),  suggesting the in- 
volvement of Btk kinase in Ib5R-mediated signaling.  We 
demonstrated that Btk was activated by 1I.-5 stimulation of 
pre-B cell lines (Figs. 8 and 9), suggesting the involvement 
of Btk kinase in IL,5R-mediated signaling. Recently, Kawakami 
et al. (64) showed that FceRI cross-linking induces rapid ac- 
tivation and tyrosine phosphorylation of Btk in mouse bone 
marrow-derived mast cells. Although we could not detect 
significant enhancement of its tyrosine phosphorylation, these 
data indicate that Btk can be modulated by extracellular signals. 
The Btk protein, which belongs to a newly identified family 
of nonreceptor tyrosine kinases, may have the potential to 
interact in a novel way with protein(s) involved in an IL-5R- 
mediated signaling pathway. One amino acid substitution was 
reported in the NH2-terminal domain unique to Btk in the 
XID mouse (42, 43),  the B cells of which fail to respond 
to II.-5 (44), indicating the importance of the correct expres- 
sion of this region of the protein in B cell responses to Ib5. 
Our findings may partly explain the B cell-specific defect in 
ID5 responsiveness in XID mice. The discovery of cellular 
molecule(s) that can interact with Btk, through its NH2-ter- 
minal unique region, should shed light on the complex sig- 
naling requirements of B cell differentiation in response to 
cytokines induding IL-5.. 
In conclusion, we have demonstrated the data suggesting 
the involvement of multiple families of signal-transducing 
molecules such as Vav, Shc, HS1, and PI-3 kinase, and cyto- 
plasmic FFKs such as JAK2 and Btk in IL-5R-mediated sig- 
naling pathways. We have failed to detect kinases associated 
with the IL-5R. However, published evidence suggests that 
theJAKs may well be associated, and our results also suggest 
the proximal location ofJAK2 kinase to IL-5R.  Successive 
immunoprecipitations using anti-Btk and anti-JAK2 kinase 
antibodies, reciprocally, followed by in vitro kinase assay, re- 
vealed no evidence for the association with each other (data 
not shown). It is still undear at this moment whether the 
Btk kinase is a proximal mediator of IL-5 response or it could 
be  downstream  of  IDSR-mediated  signaling  pathway. 
Whereas our data provide important clues for clarifying the 
precise role of signaling molecules in the development, prolifer- 
ation and differentiation of hematopoietic cells in response 
to IL5, we need more experiments to clarify the roles of acti- 
vation of Btk and JAK2 in IL-5 signaling. Furthermore, we 
should extend current studies to elucidate differences in IL- 
5R-mediated signal transduction cascades  between cell prolifer- 
ation and differentiation. 
We thank Drs. A. Miyajima (DNAX Research Institute, Palo Alto, CA), H. Yamori, Y. Yamanashi; and 
T. Yamamoto  for providing AIC2B cDNA, anti-FY mAb, and anti-Lyn antibodies, respectively. We also 
thank Drs. A. Tominaga and T. Yamamoto  for their helpful suggestions throughout this study, and Dr. 
R  Barfod for reviewing the English text. 
This work was supported in part by a Grant-in-Aids for Scientific  Research and for Special Project Re- 
search, Cancer Bioscience, for the Ministry of Education, Science and Culture of Japan. 
Address correspondence to Dr. K. Takatsu, Department of Immunology, Institute of Medical Science, 
University of Tokyo, 4-6-1 Shirokanedai Minato-ku, Tokyo 108, Japan, T. Katagiri's present address is 
Department of Immunology, Center for Basic Research, The Kitasato Institute, 5-9-1 Shirokane,  Minato- 
ku, Tokyo 108, Japan. 
Received for publication 14 February 1994  and in revised  form 23June  1994. 
~l'eaces 
1. Takatsu,  K. 1992. Interleukin-5 receptor. Curt.. Opin. Immunol. 
3:299. 
2.  Takatsu,  K., A. Tominaga,  N. Harada, S. Mita, M. Matsumoto, 
T. Takahashi, Y. Kikuchi, and N. Yamaguchi. 1988. T cell- 
replacing  factor (TRF)/interleukin 5 (IL-5): molecular  and func- 
tional properties. Imraunol. Rev. 102:107. 
3.  Tominaga,  A., S. T~kaki,  N. Koyama,  S. Katoh, R. Matsumoto, 
M. Migita, Y. Hitoshi, Y. Hosoya, S. Yamauchi,  Y. Kanai, et 
2109  Sato et al. al.  1991. Transgenic mice expressing a B cell growth and 
differentiation factor gene (interleukin 5) develop eosinophilia 
and autoantibody production. J. Exp.  Med.  173:429. 
4.  Lopez, A.F., M.J. Elliott, J. Woodcock,  and M.A. Vadas. 1992. 
GM-CSF, II-3 and I1r  cross-competition on human hae- 
mopoietic cells. Immunology  Today. 13:495. 
5.  Mita, S., A. Tominaga, Y. Hitoshi, K. Sakamoto, T. Honjo, 
M. Akagi, Y. Kikuchi, N. Yamaguchi, and K. Takatsu. 1989. 
Characterization of high-affinity  receptors for interleukin 5 on 
interleukin 5-dependent cell lines. Pro~ Natl. Acad. Sci. USA. 
86:2311. 
6.  Takaki, S., A. Tominaga, Y. Hitoshi, S. Mita, E. Sonoda, N. 
Yamaguchi, and K. Takatsu. 1990. Molecular cloning and ex- 
pressionof  the murine interleukin-5 receptor. EMBO (Eur. Mol. 
Biol. Organ.) J.  9:4367. 
7.  Devos, P., G. Plaetinck, J.V. der Heyden, S. Cornelis, J. Van- 
dekerckhove, W. Fiefs, andJ. Tavernier. 1991. Molecular basis 
of a high affinity murine interleukin-5 receptor. EMBO (Eur. 
Mol. Biol. Organ.) J.  10:2133. 
8.  Mita, S., S. Takaki, Y. Hitoshi, A.G. Rolink, A. Tominaga, 
N. Yamaguchi,  and K. Takatsu. 1991. Molecular characteriza- 
tion of the ~/chain of the murine interleukin 5 receptor. Int. 
Immunol.  3:665. 
9.  Takaki, S., S. Mita, T. Kitamura, S. Yonehara, A. Tominaga, 
N. Yamaguchi, A.  Miyajima, and K. Takatsu. 1991. Iden- 
tification of the second subunit of the murine interleukin 5 
receptor: interleukin-3 receptor-like  protein, AIC2B is a com- 
ponent of the high aff~ity  interleukin-5 receptor. EM80 (Eur. 
Mol. Biol. Organ.) J.  10:2833. 
10.  Murata, Y., S. Takaki, M. Migita, Y. Kikuchi, A. Tominaga, 
and K. Takatsu. 1992. Molecular cloning and expression of 
the human interleukin 5 receptor.  J. Ext~ Med.  175:341. 
11.  Tavernier,  J., lL. Devos, S. Cornelis, T. Tuypens, J. Van der 
Heyden, W. Fiefs, and G. Plaetinck. 1991. A human high 
affinity interleukin-5 receptor (IL5IL)  is composed of an IL5- 
specific c~ chain and a ~ chain shared with the receptor for 
GM-CSF. Cell. 6:1175. 
12.  Hara,  T., and A. Miyajima. 1992. Two distinct functional high 
affinity receptors for mouse interleukin-3 (IL-3). EMBO (Eur. 
Mol. Biol. Organ.) J.  11:1875. 
13.  Kitamura, T., K. Hayashida,  K. Sakamaki,  T. Yokota, K. Arai, 
and A. Miyajima. 1991. Reconstitution of functional receptors 
for human granulocyte/macrophage  colony-stimulating  factor 
(GM-CSF): evidence  that AIC2B is a subunit of murine GM- 
CSF receptor. Proa Natl. Acad. Sci. USA.  88:5082. 
14.  Park, L.S., U. Martin, lL. Sorensen, S. Luhr, P.J. Morrissey, 
D. Cosman, and A. Larsen. 1992. Cloning of the low-affinity 
murine  granulocyte-macrophage colony-stimulating factor 
receptor and reconstitution of a high-af~ity receptor com- 
plex. Proa Natl.  Acad. Sci. USA.  89:4295. 
15.  Hayashida, K., T. Kitamura, D.M. Gorman, K.-I. Arai, T. 
Yokota, and A. Miyajima. 1990. Molecular  cloning of  a second 
subunit of the receptor for human granulocyte-macrophage 
colony-stimulating  factor (GM-CSF): reconstitution of  a high- 
affinity  GM-CSF receptor. Pro~ Natl. Acad. Sci. USA. 87:9655. 
16.  Takaki,  S., Y. Murata, T. Kitamura, A. Miyajima,  A. Tominaga, 
and K. Takatsu. 1993. Reconstitution of  the functional  receptors 
for murine and human interleukin 5.J. Exi~ Med.  177:1523. 
17.  Sakamaki, K., I. Miyajima, T. Kitamura, and A. Miyajima. 
1992. Critical cytoplasmic  domains of the common b subunit 
of the human GM-CSF, Ib3 and Ib5 receptor for growth signal 
transduction and tyrosine phosphorylation. EMBO (Eur. Mol. 
Biol. Organ.) J.  11:3541. 
18.  Koch, C.A., D.  Anderson, M.F. Moran,  C.  Ellis, and T. 
Pawson. 1991. SH2 and SH3 domains: elements that control 
interactions of cytoplasmic signaling proteins. Science (Wash. 
DC). 252:668. 
19.  Matsuda, M.B., B.G. Mayer,  and H. Hanafusa. 1991. Identifica- 
tion of domains of the v-crk oncogene product sufficient for 
association  with phosphotyrosine-containing  proteins. Mol. Cell 
Biol.  11:1607. 
20.  Bar-Sagi,  D., D. Rotin, A. Batzer, V. Mandiyan, and J. Schles- 
singer. 1993. SH3 domains direct cellular localization of sig- 
naling molecules. Cell. 74:83. 
21.  Pelicci,  G., L. Lanf~ancone,  F. Grignani,  J. McGhde, F. Cavallo, 
G. Fomi, I. Nicoletti, F. Grignani, T. Pawson,  and P.G. Pelicci. 
1992. A novel transforming protein (SHC) with an SH2 do- 
main is implicated  in mitogenic  signal transduction.  Cell. 70:93. 
22.  Egan, S.E., B.W. Giddings, M.W. Brooks, L. Buday, A.M. 
Sizeland, and R.A. Weinberg. 1993. Association of Sos Ras 
exchange protein with Grb2 is implicated in tyrosine kinase 
signal transduction and transformation. Nature  (Lond.). 363:45. 
23.  Smith, M.R., S.J. DeGudicubus, and D.W. Stacey. 1986. Re- 
quirement for c-ras proteins during viral oncogene transfor- 
mation. Nature (Lond.). 320:540. 
24.  Satoh, T., M. Nakafuku, A. Miyajima, and Y. Kaziro. 1991. 
Involvement of p21 ~s protein in signal transduction pathways 
from interleukin 2, interleukin 3 and granulocyte/macrophage 
colony-stimulating  factor,  but not from interleukin  4. Proc Natl. 
Acad. Sci. USA.  88:3314. 
25.  Duronio, V., M.J. Welham, S. Abraham, P. Dryden, and J.W. 
Schrader. 1992. p21ras activation  via hemopoietin  receptors and 
c-kit requires tyrosine kinase activity but not tyrosine phos- 
phorylation of p21 r's GTPase-activating protein. Proc. Natl. 
Acad. Sci. USA.  89:1587. 
26.  Katzav, S., J.L. Cleveland, H.E. Heslop, and D. Pulido. 1991. 
Loss of the amino-terminal helix-loop-helix  domain of the vav 
proto-oncogene activates its transforming potential. Mol. Cell. 
Biol.  11:1912. 
27.  Kitamura, D., H. Kaneko, Y. Miyagoe, T. Ariyasu, and T. 
Watanahe. 1989. Isolation  and characterization  of  a novel  human 
gene expressed specifically  in the cells of hematopoietic lin- 
eage. Nucleic Acids Res.  17:9367. 
28.  Busteolo, X., and M. Barbacid. 1992. Tyrosine  phosphoryla- 
tion of the vav proto-oncogene product in activated B cells. 
Science (Wash. DC).  256:1196. 
29.  Yamanashi,  Y., M. Okada, T. Semba, T. Yamori, H. Umemori, 
S. Tsunasawa, K. Toyoshima,  D. Kitamura, T. Watanahe, and 
T. Yamamoto. 1993. Identification of HS1 protein as a major 
substrate of protein-tyrosine kinase(s) upon  B-cell antigen 
receptor-mediated  signaling.  Proa Natl. AcacL Sci. USA. 90:3631. 
30.  Taga,  T., and T. Kishimoto. 1992. Cytokine receptors and signal 
transduction. FASEB (Fed. Am.  Soc. Ex  F  Biol.)J.  6:3387. 
31.  Hatakeyama, M., T. Kono, N. Kobayashi,  A. Kawahara, S.D. 
l.evin, IL.M. Perlmutter, and T. Taniguchi. 1991. Interaction 
of  the  I1=2 receptor  with  the  src-family kinase p561r 
identification  of novel  intermolecular  association.  Science (Wash. 
DC). 252:1523. 
32.  Valezquez,  L., M. Fellous, G.R. Stark, and S. Pellegrini. 1992. 
A protein  tyrosine kinase in  the  interferon c~/~ signaling 
pathway. Cell. 70:313. 
33.  Witthuhn, B.A., F.W. QueUe, O. Silvenninen,  T. Yi, B. Tang, 
O.  Miura,  and J.N.  Ihle. 1993. JAK2 associates with the 
erythropoietin receptor and is erythropoietin. Cell. 74:227. 
34.  Murata, Y., N. Yamaguchi,  Y. Hitoshi, A. Tominaga, and K. 
Takatsu. 1990. Interleukin 5 and interleukin 3 induce serine 
2110  IL-5-mediated  Signal Transduction and tyrosine phosphorylation of several cellular proteins in an 
interleukin  5-dependent  cell line. Biochem. Biophys, Res. 
Commun.  173:1102. 
35.  Tsukada, S., D.C. Saffran, D.J. Rawlings, O. Parolini, K.C. 
Allen, I. Klisak, K.S. Sparkes, H. Kubagawa, T. Mohandas, 
S. Quan, et al. 1993. Deficient  expression  ofa B cell  cytoplasmic 
tyrosine kinase  in human X-linked agammaglobulinemia.  Cell. 
72:279. 
36.  Vetrie, D., I. Vorechovsky,  P. Sideras, J. Holland, A. Davies, 
F. Flinter, L. Hammarstrom,  C. Kinnon, K. Levinsky, M. 
Bobrow, et al. 1993. The gene involved in X-linked agam- 
maglobulinaemia is a member of the src family of protein- 
tyrosine kinases. Nature (Lond.). 361:226. 
37.  Pan, C.-I., R. Fukunaga, S. Yonehara, and S. Nagata. 1993. 
Unidirectional  cross-phosphorylation  between the granulocyte 
colony-stimulating factor and interleukin 3 receptor.  J. Biol. 
Chem.  268:3443. 
38.  Katagiri, T., K. Urakawa, Y. Yamanashi, K. Semba, T. Taka- 
hashi, K. Toyoshima,  T. Yamamoto, and K. Kano. 1989. Over- 
expression of src family gene for  tyrosine-kinase p59  ~  in 
CD4-CD8-  T cells of mice with a lymphoproliferative  dis- 
order. Proc Natl.  Acad. Sci. USA.  86:10064. 
39.  Yamanashi, Y., Y. Fukui, B. Wongsasant, Y. Kinoshita, Y. 
Ichimori, K. Toyoshima,  and T. Yamamoto. 1992. Activation 
of Src-like protein-tyrosine kinase Lyn and its association  with 
phosphatidyl-inositol 3-kinase upon B-cell antigen receptor- 
mediated signaling. Proc Natl. Acad.  Sci. USA.  89:1118. 
40.  Satoh,  T., Y. Uehara, and Y. Kaziro. 1992. Inhibition ofinter- 
leukin 3 and granulocyte-macrophage  colony-stimulating  factor 
stimulated increase of activity Ras-GTP by herbimycin A, a 
specific ~nhibitor of tyrosine kinases.J. Biol. Chem.  267:2537. 
41.  Yamaguchi, N., Y. Hitoshi, S. Mita, Y. Hosoya, Y. Kikuchi, 
A. Tominaga, and K. Takatsu. 1990. Characterization of the 
murine II.-5 receptors by using monoclonal anti-receptor anti- 
body. Int.  Immunol.  2:181. 
42.  Rawlings, D., D.C. Saffran,  S. Tsukada, D.A. Largaespada,  J.C. 
Grimaldi, L. Cohen, K.N. Mohr,  J.F. Bazan, M. Howard, N.G. 
Copdand, et al. 1993. Mutation of unique region of Bruton's 
tyrosine kinase in immunodeficient Xid mice. Science (Wash. 
DC). 261:358. 
43.  Thomas, J.D.,  P. Sideras, C.I.E.  Smith, I. Vorechovsky, V. 
Chapman, and W.E. Paul. 1993. Colocalization of X-linked 
agammaglobulinemia and X-linked immunodeficiency  genes. 
Science (Wash. DC).  261:355. 
44.  Hitoshi, Y., E. Sonoda, Y. Kikuchi, S. Yonehara, H. Nakanchi, 
and K. Takatsu. 1993. Interleukin-5 receptor positive B cells, 
but not eosinophils  are functionally  and numerically  influenced 
in mice carrying the X-linked  immunodeficiency.  Int. Immunol. 
5:1183. 
45.  Torigoe, T., K. O'Connor, R. Fagard, S. Fisher, D. Santoli, 
and J.C.  Reed. 1992. Interleukin-3 regulates the activity of 
the LYN protein-tyrosine kinase in myeloid-committed leu- 
kemic cell lines. Blood. 80:617. 
46.  Corey, S., A. Egninoa, K.P. Theall, J.B. Bolen, L. Cantley, 
F. Mollinedo, T.K. Jackson, P.T. Hawkins, and L.K. Stephens. 
1993. Granulocyte  macrophage-colony  stimulating  factor  stimu- 
lates both association  and activation ofphosphoinositide 3OH- 
kinase and src-related tyrosine kinase(s) in human myeloid  de- 
rived cells. EMBO (Fur. Mol. Biol. Organ.) J.  12:2681. 
47.  Mui, A.L.E, R.J. Kay,  K.K. Humphries, and K. Krystal. 1992. 
Ligand-induced phosphorylation of the murine interleukin 3 
receptor signals  its cleavage.  Proc Natl. Acad. Sci. USA. 89:10812. 
48.  Duronio, V., I.C. Lewis, B. Federsppiel,  J.S. Wieler, and J.W. 
Schrader. 1992. Tyrosine  phosphorylation  of  receptor 3 subunits 
and  common  substrates in  response to  interleukin-3  and 
granulocyte-macrophage colony-stimulating factor. J.  Biol, 
Chem.  267:21856. 
49.  Hanazono, Y., S. Chiba, K. Sasaki, H. Mano, A. Miyajima, 
K. Arai, Y. Yazaki, and H. Hirai.  1993. c-fps/fes protein- 
tyrosine kinase is implicated in a signaling pathway triggered 
by  granulocyte-macrophage colony-stimulating factor  and 
interleukin-3. EMBO (Fur. Mol.  Biol. Organ.) J.  12:1641. 
50.  Downess, C.P., and A.N. Carter. 1991. Phosphoinositide 3 
kinase: a new effector in signal transduction? Cell. Signalling. 
3:501. 
51.  Gout, I., R. Dhand, G. Panayotou,  M.J. Fry, I. Hiles, M. Otsu, 
and M.D. Waterfield. 1992. Expression and characterization 
of the p85 subunit of the phosphatidylinositol 3-kinase com- 
plex and a related p85b protein by using the baculovirus ex- 
pression system. Biochem. J.  288:395. 
52.  Wang, L.M., A.D. Keegan, W.E. Paul, M.A. Heidaran, J.S. 
Gutkind, andJ.H. Pierce. 1992. I1.-4 activates a distinct signal 
transduction  cascade  from 11.-3 in factor-dependent  myeloid  cells. 
EMBO (Eur Mol. Biol. Organ.) J.  11:4899. 
53.  Nakanishi, H., K.A. Brewer, and J.H. Extort. 1993. Activa- 
tion of the ~'isozyme of  protein kinase C by phosphatidylino- 
sitol 3,4,5-triphosphate. J. Biol. Chem.  268:13. 
54.  Berra, E., M.T. Diaz-Meco, I. Dominguez, M.M. Municio, 
L. Sanz, J. Lozano, K.S. Chapkin, and J. Moscat. 1993. Pro- 
tein kinase C ~" isoform is critical for mitogenic signal trans- 
duction. Cell. 74:555. 
55.  Valius,  M., and A. Kazlauskas. 1993. Phospholipase  C-3'1 and 
phosphatidyl-inositol 3 kinase are the downstream mediators 
of the PDGF receptor's mitogenic signal. Cell. 73:321. 
56.  Downward, J., J.D.  Graves, P. Warne, S. Rayter, and D.A. 
Cantrell.  1990. Stimulation of p21 r~ upon T-cell activation. 
Nature (Lond.). 346:719. 
57.  Graziadei,  L., K. Raibowol, and D. Bar-Sagi. 1990. Co-capping 
of ras proteins with surface immunoglobulins in B lympho- 
cytes. Nature (Lond.). 347:396. 
58.  Gulbins, E., K.M. Coggeshall, G. Baier, S. Katzav, P. Bum, 
and A.  Altman.  1993. Tyrosine kinase-stimulated guanine 
nucleotide exchange activity of  Vav in T cell activation. Science 
(Wash. DC).  260:822. 
59.  Gold, M., D.A. Law, and A.L. DeFranco. 1990. Stimulation 
of protein tyrosine phosphorylation by the B-lymphocyte an- 
tigen receptor. Nature (Lond.). 345:810. 
60.  Lamer, A.C., M. David, G.M. Feldman, K. Igarashi, K.H. 
Hackett, D.S.A. Webb, S.M. Sweitzer, E.F. Petricoin III, and 
D.S. Finbloom.  1993. Tyrosine phosphorylation  of DNA 
binding proteins by multiple cytokines. Science (Wash. DC). 
261:1730. 
61.  Argetsinger, L.S., G.S. Campbell, X. Yang, B.A. Withhuhn, 
O. Silvennoinen,  J.N. Ihle, and C. Carter-Su. 1993. Identifica- 
tion of  JAK2 as a growth hormone receptor-associated tyro- 
sine kinase. Cell'  74:237. 
62.  Stahl,  N., and G.D. Yancopoulos. 1993. The alphas, betas and 
kinases of cytokine receptor complexes. Cell. 74:587. 
63.  Silvennoinen, O., B.A.  Witthuhn, F.W. Quelle, J.L. Cleve- 
land, T. Yi, andJ.N. Ihle. 1993. Structure of the murine Jak2 
protein-tyrosine  kinase and its role in interleukin 3 signal trans- 
duction. Proc Natl. Acad. Sci. USA.  90:8429. 
64.  Kawakami,  Y., L. Yao, T. Miura, S. Tsukada, O.N. Witte, and 
T. Kawakami. 1994. Tyrosine  phosphorylation and activation 
of Bruton tyrosine kinase upon FceRI cross-linking.  Mol. Cell. 
Biol.  14:5108. 
2111  Sato et al. 